AbbVie has announced that the US Food and Drug Administration (FDA) has approved its Pfizer-partnered Emblaveo ...

Artificial intelligence (AI) is transforming various industries as a major investing theme in 2025. The technology's ability ...

It’s critical to understand what a digitally savvy HCP is in 2025 and what’s impeding pharma's communications with this ...

Allergan Aesthetics, an AbbVie (NYSE: ABBV) company, today announced Allergan Medical Institute (AMI) will open three new ...

The AIM Centre, in partnership with AbbVie and Atlantic Technological University (ATU) Sligo, successfully hosted the ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

Neomorph is building out its supply of Big Pharma partnerships, this time stamping down an option-to-license pact with AbbVie that centers around the biotech’s molecular glue platform.

Collaboration leverages AbbVie's expertise in oncology and immunology ... "At Neomorph, we have spent years building a unique molecular glue platform with broad coverage of the proteome," said ...

AbbVie cautions that these forward-looking statements ... And so, our BD efforts are focused on building pipeline depth in those areas. Now, I should say if we see an opportunity for ...

Collaboration leverages AbbVie's expertise in oncology and immunology drug development and Neomorph's leading molecular glue discovery platform Neomorph to receive ...

JPM25: AbbVie pens $1B deal for Simcere’s phase ... racks up one production contract after another, the company is busy building out its manufacturing footprint. The company's fifth ...